Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Metadata
Title
Eighth International Symposium on hereditary breast and ovarian cancer
May 4–7, 2021 – Virtual Edition
Publication date
15-09-2021
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2022
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-021-00273-x

Other articles of this Issue 3/2022

Familial Cancer 3/2022 Go to the issue

Short Communication

Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant

Original Article

A recurrent pathogenic BRCA2 exon 5–11 duplication in the Christian Arab population in Israel

Short Communication

Utility of interim blood tests for cancer screening in Li-Fraumeni syndrome

Short Communication

PTCH2 is not a strong candidate gene for gorlin syndrome predisposition

Short Communication

A de novo pathogenic variant in the MSH6 gene in a 52 years-old woman

Original Article

Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits